Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00588549 · ClinicalTrials.gov registry record
Utility of PET In the Pre-Operative Assessment of Patients With Hepatic Colorectal Metastases
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 204
- Enrollment target
NCT00588549: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00588549 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 204 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00588549 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 204 participants
- Enrollment target
Study Summary
This study aims to determine whether a test, called the PET scan, may be useful in determining if there are additional locations of cancer not otherwise detectable by other tests. The PET scan is a nuclear medicine imaging study that measures how much radioactive sugar is used by your tumor. The study will compare pictures of the cancer from the PET scan to other x-ray exams, such as a CT scan, as well as to what your doctors find at the time of surgery. If the study results show that the PET scan gives us a good idea of what is happening to the tumor, then it may be useful in deciding which patients with colorectal metastases to the liver should be operated on and what operation should be performed. Additionally, by comparing the results of PET scans with the other studies that will be performed as part of your care, we will try to determine which test best tells us which patient is most likely to benefit from surgery.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 204 participants |
| Start Date | 1998-07 |
| Est. Completion | 2009-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00588549
The ClinicalTrials.gov registry entry for NCT00588549 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 204 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00588549 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00588549 about?
NCT00588549 is a clinical study titled "Utility of PET In the Pre-Operative Assessment of Patients With Hepatic Colorectal Metastases". This study aims to determine whether a test, called the PET scan, may be useful in determining if there are additional locations of cancer not otherwise detectable by other tests. The PET scan is a nuclear medicine imaging study that measures how much radioactive sugar is used by your tumor. The st...
What is the current status of trial NCT00588549?
This trial is currently completed. The enrollment target is 204 participants. The study started on 1998-07. Estimated completion is 2009-03.
Who is sponsoring clinical trial NCT00588549?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.